3/7
07:03 pm
abus
Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook [Yahoo! Finance]
Medium
Report
Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook [Yahoo! Finance]
3/4
05:00 pm
abus
Why Moderna (MRNA) Stock Is Trading Up Today [Yahoo! Finance]
Neutral
Report
Why Moderna (MRNA) Stock Is Trading Up Today [Yahoo! Finance]
3/4
10:13 am
abus
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement [Yahoo! Finance]
Medium
Report
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement [Yahoo! Finance]
3/4
09:22 am
abus
Moderna gains as Arbutus/ Genevant settlement removes major financial risk [Seeking Alpha]
Medium
Report
Moderna gains as Arbutus/ Genevant settlement removes major financial risk [Seeking Alpha]
3/4
09:21 am
abus
Moderna shares jump as settlement removes major legal overhang [Yahoo! Finance]
Low
Report
Moderna shares jump as settlement removes major legal overhang [Yahoo! Finance]
3/3
04:15 pm
abus
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
High
Report
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
2/3
08:00 am
abus
Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts [Seeking Alpha]
Medium
Report
Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts [Seeking Alpha]
1/23
05:06 am
abus
Arbutus Biopharma (NASDAQ:ABUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Arbutus Biopharma (NASDAQ:ABUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.